Suppr超能文献

相似文献

2
DeSUMOylating enzymes--SENPs.
IUBMB Life. 2008 Nov;60(11):734-42. doi: 10.1002/iub.113.
5
Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases.
Biochim Biophys Acta. 2016 Jan;1863(1):139-47. doi: 10.1016/j.bbamcr.2015.10.020. Epub 2015 Oct 30.
6
Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
J Biol Chem. 2011 Oct 14;286(41):36142-36151. doi: 10.1074/jbc.M111.268847. Epub 2011 Aug 30.
7
Characterization of SENP7, a SUMO-2/3-specific isopeptidase.
Biochem J. 2009 Jun 26;421(2):223-30. doi: 10.1042/BJ20090246.
8
A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex.
Structure. 2004 Aug;12(8):1519-31. doi: 10.1016/j.str.2004.05.023.
9
Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates.
Nat Struct Mol Biol. 2006 Dec;13(12):1060-8. doi: 10.1038/nsmb1168. Epub 2006 Nov 12.
10
Differential regulation of sentrinized proteins by a novel sentrin-specific protease.
J Biol Chem. 2000 Feb 4;275(5):3355-9. doi: 10.1074/jbc.275.5.3355.

引用本文的文献

2
SENP1-SIRT3 axis mediates glycolytic reprogramming to suppress inflammation during infection.
mBio. 2025 Apr 9;16(4):e0252424. doi: 10.1128/mbio.02524-24. Epub 2025 Mar 12.
3
SUMOylation and DeSUMOylation: Tug of War of Pain Signaling.
Mol Neurobiol. 2025 Mar;62(3):3305-3321. doi: 10.1007/s12035-024-04478-w. Epub 2024 Sep 14.
4
Characterizing the differential distribution and targets of Sumo1 and Sumo2 in the mouse brain.
iScience. 2023 Mar 9;26(4):106350. doi: 10.1016/j.isci.2023.106350. eCollection 2023 Apr 21.
6
TCR-Induced Tyrosine Phosphorylation at Tyr270 of SUMO Protease SENP1 by Lck Modulates SENP1 Enzyme Activity and Specificity.
Front Cell Dev Biol. 2022 Feb 2;9:789348. doi: 10.3389/fcell.2021.789348. eCollection 2021.
7
SUMOylation in Viral Replication and Antiviral Defense.
Adv Sci (Weinh). 2022 Mar;9(7):e2104126. doi: 10.1002/advs.202104126. Epub 2022 Jan 21.
8
Isopeptidase Kinetics Determination by a Real Time and Sensitive qFRET Approach.
Biomolecules. 2021 Apr 30;11(5):673. doi: 10.3390/biom11050673.
10
A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation).
Biochem Biophys Rep. 2021 Jan 8;25:100873. doi: 10.1016/j.bbrep.2020.100873. eCollection 2021 Mar.

本文引用的文献

1
A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex.
Structure. 2004 Aug;12(8):1519-31. doi: 10.1016/j.str.2004.05.023.
2
RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
J Cell Biol. 2004 Mar 29;164(7):965-71. doi: 10.1083/jcb.200309126. Epub 2004 Mar 22.
3
SUMO: a regulator of gene expression and genome integrity.
Oncogene. 2004 Mar 15;23(11):1998-2008. doi: 10.1038/sj.onc.1207415.
4
Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15758-63. doi: 10.1073/pnas.2136933100. Epub 2003 Dec 8.
5
SUMO-2/3 regulates topoisomerase II in mitosis.
J Cell Biol. 2003 Nov 10;163(3):477-87. doi: 10.1083/jcb.200304088. Epub 2003 Nov 3.
6
Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1.
J Biol Chem. 2004 Jan 2;279(1):692-703. doi: 10.1074/jbc.M306195200. Epub 2003 Oct 16.
8
PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.
J Biol Chem. 2003 Nov 28;278(48):47434-40. doi: 10.1074/jbc.M308562200. Epub 2003 Sep 18.
10
Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3.
J Biol Chem. 2003 Aug 29;278(35):33416-21. doi: 10.1074/jbc.M305680200. Epub 2003 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验